The symptoms, auxological characteristics, and stimulated 17-hydroxyprogesterone (17-OHP) concentrations in a group of patients with non-classical 21-hydroxylase deficiency (NCCAH) were compared with those of their siblings. Ten index cases consisting of nine females and one male patient aged 3-33 years and 16 siblings were studied. In the sibling group five subjects were slightly virilised and of these, two females were found to have NCCAH according to 
Abstract
The symptoms, auxological characteristics, and stimulated 17-hydroxyprogesterone (17-OHP) concentrations in a group of patients with non-classical 21-hydroxylase deficiency (NCCAH) were compared with those of their siblings. Ten index cases consisting of nine females and one male patient aged years and 16 siblings were studied. In the sibling group five subjects were slightly virilised and of these, two females were found to have NCCAH according to their stimulated 17-OHP concentrations. The remaining nine siblings, who were not virilised, all had normal stimulated 17-OHP concentrations. Among the total NCCAH group (index cases and affected siblings) eight patients had the diagnosis made within two years of the onset of symptoms. In four patients diagnosis was del:yed until adulthood. In seven patients investigated, bone age was significantly increased before treatment. The mean height and body mass index Z scores of the affected patients as a total group or when divided according to skeletal maturity were not significantly different from either the normal mean or from their unaffected siblings. Virilised The discovery of the non-classical and cryptic (or asymptomatic) forms of CAH was the result of detailed screening studies on families of patients with the classic forms of CAH. In these studies, affected relatives were identified using a combination of hormonal markers and genetic markers (HIA B 14).7 8 The non-classical form of CAH has subsequently been the subject of several family studies.7 9-14 These studies found both symptomatic and asymptomatic relatives with similar endocrine and genetic profiles to the propositi. This raises the possibility that phenotypically normal siblings of children with' this condition may have the cryptic form of CAH. We report on the auxological and endocrine status of propositi and siblings from 10 families in which at least one member was affected by NCCAH. All assays were performed by the department of clinical biochemistry at the Royal Children's Hospital in Melbourne. The radioimmunoassays used to assess serum testosterone and 1 7-OHP levels have been previously reported. '9 Serum sodium was measured potentiometrically, using the Kodak Ektachem 700, and plasma renin activity was measured by radioimmunoassay of generated angiotensin I (CIS Sorin Biomedica) using a previously reported method.20 Urinary pregnanetriol concentrations were measured using gas chromatography/mass spectrometry.
Patients
Normal ranges for Synacthen stimulated 17-OHP have been determined at our laboratory using six normal adult females with regular menses, and no hirsutism or acne. The results concur with a series of 102 persons of varying ages.21
Statistical analyses were performed using the Minitab program. Comparisons of height and body mass index (BMI) data were made using standard t tests, except for the comparisons of heights of affected adult patients with their siblings, where the Wilcoxon rank-sum test was used. Z scores were calculated by subtracting the mean from the raw score and dividing by the standard deviation.
Results
The raw data obtained from studies on the NCCAH cases and their siblings are shown in tables 1 to 3. The sibships are shown in the figure. This study was in part retrospective and hence the data collection has not been entirely uniform. The results are grouped into clinical data relating to the presentation of those with NCCAH (table 1) , and endocrine/auxological data of NCCAH patients ( (2) between those whose epiphyses had yet to close. The rationale for separating these groups was to determine more accurately the effects of androgen excess on growth. In the former group androgen excess may cause premature epiphyseal closure and decreased height Z scores, whereas in the latter group accelerated growth and increased height Z scores could be expected.
The mean height Z scores of the affected patients were not significantly different from those of the standards (p=0 96), whereas the mean height Z scores of the unaffected siblings were significantly greater than the standards (mean Z score=0-49, p=0 04). In the unaffected sibling group neither those who had reached their final adult height nor those who were still growing had mean Z scores that were significantly different from the mean (p=0-16 for both groups).
There was no statistically significant difference between the heights of the affected patients, prior to skeletal maturity, and their unaffected siblings (p=0 90). Similarly, mature heights of index cases were not significantly different from their mature siblings (p=0-12).
Body mass index: NCCAH and unaffected siblings BMI data were available for the same patients on whom height data were available. The mean BMI Z scores of the affected patients and their unaffected siblings were not significantly different in either childhood or adulthood (p=0-46, p=047 respectively). Furthermore neither the affected patients nor their normal siblings had BMI Z scores that were significantly different from those of the standards (p=0.23, p=0f13 respectively). We were unable to find any previous reports of auxological comparisons within NCCAH sibships. Apart from the height Z score of unaffected siblings, there were no significant differences in either height or BMI between the NCCAH patients and their unaffected siblings and the standard data. Among the unaffected siblings, neither those of mature height nor the immature subgroup appeared to be responsible for the increased mean height of the group as a whole, and this seemed to be a chance phenomenon. Thus our data suggest that the mild androgen excess seen in NCCAH does not cause a marked increase in growth velocity in childhood or result in clinically significant premature epiphyseal fusion and reduction in final adult height. This contrasts with reports of patients with classical CAH, who frequently show a marked decrease in stature compared with standard populations.32-34 In the seven patients who had an estimate of bone age performed, all had values greater than their chronological ages, the mean increase being 1-3 years (or one third of their chronological age).
Therefore the consequences of not treating these patients appear to relate largely to infertility, menstrual irregularity, cosmetic appearance, and psychological sequelae. While our group were not significantly shorter as adults, the advancement in bone age may be of concern, and larger untreated groups should be studied to assess the true incidence of premature epiphyseal fusion and short adult stature.
NCCAH due to 21-hydroxylase can be difficult to recognise clinically and its natural history can vary considerably. As is evidenced by our cohort, there is often a significant delay in diagnosis, with unnecessary patient distress even in patients with a family history of the disease. The short Synacthen test is rapid, simple, and inexpensive. It should be an integral part of any approach to investigating premature pubarche, hirsutism, or the symptoms of PCO. If non-classical 21-hydroxylase deficiency is diagnosed, then symptomatic siblings should also be routinely screened for the disease.
